Georgia Sarquella Brugada
Jefe de Grupo
Research group
Research line:
Pediatric arrhythmias, genetic cardiology and sudden death
Georgia Sarquella-Brugada graduated in Medicine in 2001 from the University of Barcelona and obtained her Doctor of Medicine degree from the University of Barcelona in 2015. She has a master's degree in pediatric cardiology from the University of Barcelona, a pediatric electrophysiology master's degree from the University of Alcalà; and postgraduate degree in Medical Genetics from the University of Valencia and Familial Heart Diseases from the Menéndez Pelayo University.
Between 2007 and 2009 she did a fellowship at the Hôspital Sainte Justine in Montréal, Canada and from 2009 to 2011 at the necker Enfants Malades in Paris.
Since 2012 she has been a professor at the University of Girona and coordinator of the European Network of Rare Cardiac Diseases in Pediatrics.
In 2011 she joined the Cardiology service as an assistant and since 2015 she has been Head of the Arrhythmia Unit at Hospital Sant Joan de Déu.
She currently leads the research group on pediatric arrhythmias, genetic cardiology and sudden death and how to apply this knowledge in personalized therapies in patients with genetic diseases.
Last Publications
- Martínez-Barrios E, Greco A, César-Díaz S, Díez-López C, Cruzalegui JC, Nuria Díez Escuté, Patricia Cerralbo Martín, Chipa F, Zschaeck-Luzardo I, Grassi S, Oliva A, Balderrábano N, Toro R, Sarquella-Brugada G and Campuzano O Appropriate time interval to update ambiguous genetic diagnosis in inherited arrhythmogenic syndromes. iScience . 28(5): 112300-112300.
- Zanchi, B, Monachino, G, Faraci, FD, Metaldi, M, Brugada, P, Sarquella-Brugada G, Behr, ER, Brugada-Terradellas J, Crotti, L, Belhassen, B and Conte, G Synthetic electrocardiograms for Brugada syndrome: from data generation to expert cardiologists evaluation european heart journal - digital health . : .
- Behr ER, Winkel BG, Ensam B, Alfie A, Arbelo E, Berry C, Cerrone M, Conte G, Crotti L, Corcia CMG, Kaski JC, Nademanee K, Postema PD, Priori S, Probst V, Sarquella-Brugada G, Schulze-Bahr E, Tadros R, Wilde A and Tfelt-Hansen J The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace . 27(4): .
Projects
- Project name:
- Monitorització remota cardíaca de pacients pediàtrics. Impacte social, mediambiental i de salut.
- Leader
- Georgia Sarquella Brugada
- Funding entities:
- ÁREA METROPOLITANA DE BARCELONA (AMB)
- Code
- 900623
- Starting - finishing date:
- 2023 - 2024
- Project name:
- Creación de un programa personalizado de actividad física dirigida para deportistas de competición diagnosticados de un síndrome hereditario asociado a muerte súbita (PAC-SAMS).
- Leader
- Georgia Sarquella Brugada
- Funding entities:
- Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD, Consejo Superior de Deportes, Martínez Barrios, Estefanía
- Code
- 74742
- Starting - finishing date:
- 2023 - 2023
- Project name:
- Identificación de predictores de arritmias cardiacas y muerte súbita en pacientes pediatricos afectos de enfermedades neuromusculares
- Leader
- Georgia Sarquella Brugada
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI21/00094
- Starting - finishing date:
- 2022 - 2026
News
-
Detecting long QT syndrome early could help reduce the impact of sudden infant death
A team led by Dra. Georgia Sarquella (IRSJD) and Drs. Ramon Brugada and Oscar Campuzano (IDIBGI) provide new diagnostic measures to prevent sudden infant death from long QT syndrome.
-
First scientific conference on nanotechnology and rare diseases
The Spanish nanomedicine platform (Nanomed Spain), together with the Sant Joan de Déu Research Institute and the IBEC (Institute of Bioengineering of Catalonia), organised an event within the framework of the Rare Disease Day at which they presented the latest innovations in the field of nanomedicine for the treatment and diagnosis of these diseases.